Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating ...

Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the ...

Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for ...

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Please provide the article or its content so I can generate an SEO-friendly meta description according to your instructions.

Thermo Fisher (TMO) lifts 2025 outlook with strong sales and margin gains. Fair value estimate near $570 provides a limited ...

Thermo Fisher Scientific’s plan for growth is paying off as the biopharma service provider and supplier posted a sales bump ...

Low-cost index funds make it easy to achieve average market returns. But in any diversified portfolio of stocks, ...

Young innovators recognized with $100K for STEM research advancing science and tackling global challenges Congratulations to ...

Thermo Fisher Scientific shares rise after announcing $8.875B acquisition of Clario, enhancing AI-powered clinical trials and ...

In the last three months, 8 analysts have published ratings on Thermo Fisher Scientific (NYSE:TMO), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a ...